[Progress in nephrology during this year: Basic research for kidney diseases].
Nangaku
Masaomi
M
Inagi
Reiko
R
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000818:Animals; D018450:Disease Progression; D015195:Drug Design; D004921:Erythropoietin / Q000627:therapeutic use; D005355:Fibrosis; D006801:Humans; D051793:Hypoxia-Inducible Factor 1 / Q000819:agonists; D007668:Kidney / Q000473:pathology; D007674:Kidney Diseases / Q000209:etiology / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D009398:Nephrology / Q000639:trends*; D012084:Renin-Angiotensin System / Q000502:physiology
D047228:Angiotensin II Type 1 Receptor Blockers; D051793:Hypoxia-Inducible Factor 1; D004921:Erythropoietin